Robinson Tom
Department of Theory & Bio-Systems, Max Planck Institute of Colloids and Interfaces, Potsdam, 14424, Germany.
Adv Biosyst. 2019 Jun;3(6):e1800318. doi: 10.1002/adbi.201800318. Epub 2019 May 7.
One of the goals of synthetic biology is the bottom-up construction of an artificial cell, the successful realization of which could shed light on how cellular life emerged and could also be a useful tool for studying the function of modern cells. Using liposomes as biomimetic containers is particularly promising because lipid membranes are biocompatible and much of the required machinery can be reconstituted within them. Giant lipid vesicles have been used extensively in other fields such as biophysics and drug discovery, but their use as artificial cells has only recently seen an increase. Despite the prevalence of giant vesicles, many experiments remain challenging or impossible due to their delicate nature compared to biological cells. This review aims to highlight the effectiveness of microfluidic technologies in handling and analyzing giant vesicles. The advantages and disadvantages of different microfluidic approaches and what new insights can be gained from various applications are introduced. Finally, future directions are discussed in which the unique combination of microfluidics and giant lipid vesicles can push forward the bottom-up construction of artificial cells.
合成生物学的目标之一是自下而上构建人工细胞,其成功实现有望揭示细胞生命的起源,还可作为研究现代细胞功能的有用工具。使用脂质体作为仿生容器尤其具有前景,因为脂质膜具有生物相容性,且许多所需的机制可以在其中重构。巨型脂质囊泡已在生物物理学和药物发现等其他领域广泛应用,但将其用作人工细胞只是最近才有所增加。尽管巨型囊泡很普遍,但与生物细胞相比,由于其性质脆弱,许多实验仍然具有挑战性或无法进行。本综述旨在强调微流控技术在处理和分析巨型囊泡方面的有效性。介绍了不同微流控方法的优缺点以及各种应用可获得的新见解。最后,讨论了未来的方向,其中微流控技术与巨型脂质囊泡的独特结合可以推动人工细胞的自下而上构建。